Provided by Tiger Trade Technology Pte. Ltd.

ARS PHARMACEUTICALS INC

4.56
+0.20004.59%
Post-market: 4.590.0296+0.65%19:30 EDT
Volume:1.59M
Turnover:7.14M
Market Cap:453.48M
PE:-2.10
High:4.64
Open:4.35
Low:4.21
Close:4.36
52wk High:13.15
52wk Low:3.99
Shares:99.45M
Float Shares:48.03M
Volume Ratio:1.00
T/O Rate:3.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1757
EPS(LYR):-1.7400
ROE:-210.35%
ROA:-48.02%
PB:36.24
PE(LYR):-2.62

Loading ...

Aug 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2025

Major Issues Report

Form 8-K - Current report
Jul 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 26, 2025

Major Issues Report

Form 8-K - Current report
Jun 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 14, 2025

Major Issues Report

Form 8-K - Current report
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2025

Major Issues Report

Form 8-K - Current report
Apr 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 20, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 20, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 20, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Major Issues Report

Form 8-K - Current report